Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The International Study of Inflammation in COVID-19: A Prospective Multi-Center Observational Study Examining the Role of Biomarkers of Inflammation in Predicting Covid-19 Related Outcomes in Hospitalized Patients

NCT04818866 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT04818866
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04818866 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The International Study of Inflammation in COVID-19: A Prospective Multi-Center Observational Study Examining the Role of Biomarkers of Inflammation in Predicting Covid-19 Related Outcomes in Hospitalized Patients
Lead sponsor
University of Michigan
Phase
Observational
Overall status
Completed
Start date
February 1, 2020
Completion date
December 1, 2022
Enrollment
4,463 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, covid19, inflammation, outcome, fatal, respiratory failure